These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32739420)

  • 1. Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome.
    Liu X; Ducasa GM; Mallela SK; Kim JJ; Molina J; Mitrofanova A; Wilbon SS; Ge M; Fontanella A; Pedigo C; Santos JV; Nelson RG; Drexler Y; Contreras G; Al-Ali H; Merscher S; Fornoni A
    Kidney Int; 2020 Nov; 98(5):1275-1285. PubMed ID: 32739420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.
    Pedigo CE; Ducasa GM; Leclercq F; Sloan A; Mitrofanova A; Hashmi T; Molina-David J; Ge M; Lassenius MI; Forsblom C; Lehto M; Groop PH; Kretzler M; Eddy S; Martini S; Reich H; Wahl P; Ghiggeri G; Faul C; Burke GW; Kretz O; Huber TB; Mendez AJ; Merscher S; Fornoni A
    J Clin Invest; 2016 Sep; 126(9):3336-50. PubMed ID: 27482889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.
    Ducasa GM; Mitrofanova A; Mallela SK; Liu X; Molina J; Sloan A; Pedigo CE; Ge M; Santos JV; Hernandez Y; Kim JJ; Maugeais C; Mendez AJ; Nair V; Kretzler M; Burke GW; Nelson RG; Ishimoto Y; Inagi R; Banerjee S; Liu S; Szeto HH; Merscher S; Fontanesi F; Fornoni A
    J Clin Invest; 2019 Jul; 129(8):3387-3400. PubMed ID: 31329164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome.
    Ge M; Molina J; Kim JJ; Mallela SK; Ahmad A; Varona Santos J; Al-Ali H; Mitrofanova A; Sharma K; Fontanesi F; Merscher S; Fornoni A
    Elife; 2023 May; 12():. PubMed ID: 37129368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.
    Mitrofanova A; Molina J; Varona Santos J; Guzman J; Morales XA; Ducasa GM; Bryn J; Sloan A; Volosenco I; Kim JJ; Ge M; Mallela SK; Kretzler M; Eddy S; Martini S; Wahl P; Pastori S; Mendez AJ; Burke GW; Merscher S; Fornoni A
    Kidney Int; 2018 Dec; 94(6):1151-1159. PubMed ID: 30301568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases.
    Mitrofanova A; Fontanella A; Tolerico M; Mallela S; Molina David J; Zuo Y; Boulina M; Kim JJ; Santos J; Ge M; Sloan A; Issa W; Gurumani M; Pressly J; Ito M; Kretzler M; Eddy S; Nelson R; Merscher S; Burke G; Fornoni A
    J Am Soc Nephrol; 2022 Dec; 33(12):2153-2173. PubMed ID: 36198430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin protects podocytes in diabetic kidney disease.
    Merscher-Gomez S; Guzman J; Pedigo CE; Lehto M; Aguillon-Prada R; Mendez A; Lassenius MI; Forsblom C; Yoo T; Villarreal R; Maiguel D; Johnson K; Goldberg R; Nair V; Randolph A; Kretzler M; Nelson RG; Burke GW; Groop PH; Fornoni A;
    Diabetes; 2013 Nov; 62(11):3817-27. PubMed ID: 23835338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCDC92 promotes podocyte injury by regulating PA28α/ABCA1/cholesterol efflux axis in type 2 diabetic mice.
    Zuo FW; Liu ZY; Wang MW; Du JY; Ding PZ; Zhang HR; Tang W; Sun Y; Wang XJ; Zhang Y; Xie YS; Wu JC; Liu M; Wang ZY; Yi F
    Acta Pharmacol Sin; 2024 May; 45(5):1019-1031. PubMed ID: 38228909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease.
    Zhao C; Li L; Li C; Tang C; Cai J; Liu Y; Yang J; Xi Y; Yang M; Jiang N; Han Y; Liu Y; Luo S; Xiao L; Sun L
    Mol Med; 2022 Sep; 28(1):117. PubMed ID: 36138342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ins-and-outs of podocyte lipid metabolism.
    Meyer-Schwesinger C
    Kidney Int; 2020 Nov; 98(5):1087-1090. PubMed ID: 33126971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.
    Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A
    EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease.
    Zhang J; Wu Y; Zhang J; Zhang R; Wang Y; Liu F
    Metabolism; 2023 Feb; 139():155377. PubMed ID: 36521550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice.
    Yin QH; Zhang R; Li L; Wang YT; Liu JP; Zhang J; Bai L; Cheng JQ; Fu P; Liu F
    J Biol Chem; 2016 Dec; 291(51):26487-26501. PubMed ID: 27784780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small GTPase Arf6 regulates diabetes-induced cholesterol accumulation in podocytes.
    Hu J; Yang Q; Chen Z; Liang W; Feng J; Ding G
    J Cell Physiol; 2019 Dec; 234(12):23559-23570. PubMed ID: 31206670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease.
    Wright MB; Varona Santos J; Kemmer C; Maugeais C; Carralot JP; Roever S; Molina J; Ducasa GM; Mitrofanova A; Sloan A; Ahmad A; Pedigo C; Ge M; Pressly J; Barisoni L; Mendez A; Sgrignani J; Cavalli A; Merscher S; Prunotto M; Fornoni A
    Nat Commun; 2021 Aug; 12(1):4662. PubMed ID: 34341345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
    Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
    FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.
    Ding W; Yousefi K; Goncalves S; Goldstein BJ; Sabater AL; Kloosterboer A; Ritter P; Lambert G; Mendez AJ; Shehadeh LA
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
    Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
    Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.